- VistaGen Therapeutics (NASDAQ:VTGN): Q3 GAAP EPS of -$0.30 misses by $0.15.
- Cash and equivalents of $7.83M
- Press Release
VistaGen Therapeutics misses by $0.15
Recommended For You
More Trending News
About VTGN Stock
Related Stocks
| Symbol | Last Price | % Chg |
|---|---|---|
| VTGN | - | - |
| Vistagen Therapeutics, Inc. | ||